ArriVent BioPharma Cash Flow Statement 2021-2024 | AVBP

Fifteen years of historical annual cash flow statements for ArriVent BioPharma (AVBP).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-69.33$-36.91$-51.61
$0$0$0
$0.90$0.42$42.96
$0.90$0.42$42.96
$0$0$0
$0$0$0
$1.38$2.80$0.29
$9.66$-13.56$-5.76
$12.60$-7.15$-3.94
$-55.84$-43.63$-12.59
$0$0$0
$0$0$0
$0$0$0
$0.00$0$0
$0$0$0
$0$0$0
$0$0$0
$0.00$0$-40.00
$0$0$0
$0$0$0
$0$0$0
$0.35$0.02$0.00
$45.27$170$89.87
$0$0$0
$-2.41$0$0
$42.86$170$89.87
$-12.98$126$37.28
$0.90$0.42$0.05
$0$0$0